Beyond the Pandemic: Can Pharma Supply Chains Handle the Wegovy Ramp Up?
Join industry and Bloomberg experts for a webinar discussing these topics.
- The unique challenges of Pharma Supply Chains
- China, India and the growth of GLP-1 drugs
- Important industry logistics trends in 2024
Speakers
Matthew Ekroth
EMEA Corporate Data Strategy
Bloomberg
Matthew Ekroth leads the EMEA Data Strategy effort for Corporate clients. Matt specialises in helping clients solve supply chain problems with Bloomberg's Supply Chain, ESG and Sanctions products. Matt spent over 15 years as a quantitative equities Portfolio Manager at firms including Goldman Sachs and Engineers Gate in both London and New York. More recently he headed data strategy for equities trading at Morgan Stanley in London. Matt holds an MSc in Finance from London Business School.
Philip Ashton
Co-Founder
7bridges
Philip co-founded 7bridges, driven by his first-hand experience of the challenges of building data and outcome driven supply chains. Having delivered data-led software projects at Oliver Wyman and World Courier, an AmerisourceBergen company, and with his background in applied data science (Cambridge University), Philip recognised the technology and data is available to make the transition to smarter supply chains successfully, and his experience across verticals led him to believe it is now more critical than ever.
Samuel Herbert
Executive Chairman
7bridges
Sam is the Executive Chairman at 7bridges. He has spent the last decade leading pharmaceutical services companies including being the President of World Courier and the COO of Clinigen. Sam was educated at Harvard College and has been a Board Member and investor in a number of technology companies including 7bridges.